I asked the below question during the Q&A to encourage Leslie to discuss both immediate steps and longer-term strategies to reassure investors on their growth path… whilst not answered in its entirety, the moderator certainly picked out some core themes to focus on and some answers were further clarified...
"Given the recent fluctuations in Imugene’s share price and the competitive landscape, could you elaborate on the strategic initiatives you’re prioritising to drive sustained growth and investor value? How are you positioning Imugene to navigate challenges and capitalise on opportunities in the market over the next 12-24 months, particularly regarding clinical milestones and potential partnerships?"
IMU Price at posting:
4.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)